Phase 1 trial results indicate that combining inotuzumab ozogamicin with dose-adjusted EPOCH chemotherapy could offer a safe, well-tolerated, and effective treatment option for patients with relapsed or refractory CD22+ B-cell acute lymphoblastic leukemia or lymphoma (R/R B-ALL).
EUROAPI Announces New Governance
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Ferring Pharmaceuticals appoints new Executive Chairman among key changes to Board of Directors
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Sanofi appoints new leaders to Executive Committee and announces future Chair of EUROAPI
Viviane Monges joins Sanofi as Chair of the Supervisory Board of EUROAPI
Roy Papatheodorou appointed EVP, General Counsel and Head of Legal, Ethics & Business Integrity
Brendan O Callaghan appointed EVP, Global Head of Industrial Affairs
P
ly 29, 2021 - Karen Linehan and Philippe Luscan, who have led Legal, Ethics & Business Integrity (LEBI) and Industrial Affairs at Sanofi for the last 14 and 13 years respectively have decided to retire. Karen will retire on December 31, 2021 and Philippe later in 2022. Sanofi has appointed Roy Papatheodorou and Brendan O Callaghan as their respective replacements, joining the company s Executive Committee.